Pfizer's 2026 revenue midpoint of $61B and EPS midpoint of $2.90 decline YoY, reflecting persisting headwinds. Read more on ...
4don MSN
2 Predictions for Pfizer in 2026
Pfizer recently announced its guidance for 2026. One thing seems clear: Its financial results won't get much stronger. It ...
Pfizer enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution. Click here to read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback